Page last updated: 2024-11-07

adenophostin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

adenophostin A: structure given in first source; an inositol-1,4,5-trisphosphate agonist isolated from Penicillium brevicompactum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123695
CHEMBL ID204385
CHEBI ID34524
MeSH IDM0225807

Synonyms (18)

Synonym
149091-92-9
adenophostin a
2'-adenylic acid, 3'-o-(3,4-di-o-phosphono-alpha-d-glucopyranosyl)-
2-[5-(6-amino-9h-9-purinyl)-2-hydroxymethyl-4-oxyphosphate-(2r,3r,4r,5r)-tetrahydro-3-furanyloxy]-6-hydroxymethyl-4,5-dioxyphosphate-(2r,3r,4s,5r,6r)-tetrahydro-2h-3-pyranol
bdbm50184325
AC1L3X4M ,
[(2r,3r,4r,5r)-2-(6-aminopurin-9-yl)-4-[(2r,3r,4r,5r,6r)-3-hydroxy-6-(hydroxymethyl)-4,5-diphosphonooxyoxan-2-yl]oxy-5-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate
chebi:34524 ,
CHEMBL204385 ,
2s7ar5svd7 ,
unii-2s7ar5svd7
adenophostin
gtpl4124
{[(2r,3r,4r,5r)-2-(6-amino-9h-purin-9-yl)-4-{[(2r,3r,4r,5r,6r)-3-hydroxy-6-(hydroxymethyl)-4,5-bis(phosphonooxy)oxan-2-yl]oxy}-5-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid
[(2r,3r,4r,5r)-2-(6-aminopurin-9-yl)-4-[(2r,3r,4r,5r,6r)-3-hydroxy-6-(hydroxymethyl)-4,5-diphosphonooxy-tetrahydropyran-2-yl]oxy-5-(hydroxymethyl)tetrahydrofuran-3-yl] dihydrogen phosphate
DTXSID10164167
Q4682254
2'-adenylic acid, 3'-o-(3,4-di-o-phosphono-.alpha.-d-glucopyranosyl)-

Research Excerpts

Overview

Adenophostin A (AdA) is a potent agonist of the d-myo-inositol 1,4,5-trisphosphate receptor. AdA is a glyconucleotide natural product with the highest known potency.

ExcerptReferenceRelevance
"Adenophostin A (AdA) is a potent agonist of inositol 1,4,5-trisphosphate receptors (IP(3) R). "( Selective determinants of inositol 1,4,5-trisphosphate and adenophostin A interactions with type 1 inositol 1,4,5-trisphosphate receptors.
Potter, VL; Riley, AM; Rossi, AM; Sureshan, KM; Taylor, CW, 2010
)
2.05
"Adenophostin A (AdA) is a potent agonist of the d-myo-inositol 1,4,5-trisphosphate receptor (Ins(1,4,5)P3R). "( 2-Position base-modified analogues of adenophostin A as high-affinity agonists of the D-myo-inositol trisphosphate receptor: in vitro evaluation and molecular modeling.
Potter, BV; Sureshan, KM; Taylor, CW; Tovey, SC; Trusselle, M, 2008
)
2.06
"Adenophostin A is a glyconucleotide natural product with the highest known potency for the D-myo-inositol 1,4,5-trisphosphate receptor. "( Inframolecular studies of the protonation of adenophostin A: comparison with 1-D-myo-inositol 1,4,5-trisphosphate.
Felemez, M; Marwood, RD; Potter, BV; Spiess, B, 1999
)
2.01
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
disaccharide phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Inositol 1,4,5-trisphosphate receptor type 1 Rattus norvegicus (Norway rat)EC50 (µMol)0.04580.00150.41308.6340AID1560696; AID1606915; AID261530; AID270919; AID495142; AID661327
Inositol 1,4,5-trisphosphate receptor type 1 Rattus norvegicus (Norway rat)Kd0.00550.00020.02070.1288AID1560698; AID495143
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneInositol 1,4,5-trisphosphate receptor type 1 Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID231372Ratio to Ins(1,4,5)P3, for the effect on [Ca2+] release from the intracellular stores of permealized hepatocytes (ratio greater than 1 denotes greater potency and less than -1 denotes lesser potency)2001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.
AID1560696Agonist activity at rat IP3R1 expressed in human HEK cells assessed as increase in calcium release by Mag-fluo4 dye based assay
AID261530Agonistic potency at rat IP3 type 1 receptor expressed in chicken DT40 cells2006Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6
A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of beta-C-glucoside trisphosphates based on the conformational restriction strategy.
AID270920Activity at rat IP3 type 1 receptor expressed in DT40 cell assessed as calcium ion mobilization relative to IP32006Journal of medicinal chemistry, Sep-21, Volume: 49, Issue:19
Synthesis of adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligands.
AID495157Agonist activity to rat recombinant IP3R1 expressed in chicken DT40 cells assessed as calcium release from intracellular stores at maximum effective concentration2009Nature chemical biology, Sep, Volume: 5, Issue:9
Synthetic partial agonists reveal key steps in IP3 receptor activation.
AID195059Fraction of total [Ca2+] stores released by a maximal concentration of the compound2001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.
AID1606922Ratio of EC50 for agonist activity at rat IP3R1 expressed in HEK cells assessed as increase in calcium release in cytosol by measuring fluorescence signal by Mag-Fluo4 dye based assay to Kd for binding affinity to IP3R1 in Wistar rat cerebellar membrane2020Journal of medicinal chemistry, 05-28, Volume: 63, Issue:10
Both d- and l-Glucose Polyphosphates Mimic d-
AID226479Hill coefficient for the effect on [Ca2+] release from the intracellular stores of permealized hepatocytes2001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.
AID1560699Ratio of EC50 of rat IP3R1 expressed in human HEK cells to Kd of rat IP3R1 expressed in human HEK cells
AID261531Activity at rat IP3 type 1 receptor expressed in chicken DT40 cell by calcium release2006Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6
A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of beta-C-glucoside trisphosphates based on the conformational restriction strategy.
AID270919Activity at rat IP3 type 1 receptor expressed in DT40 cell assessed as calcium ion mobilization2006Journal of medicinal chemistry, Sep-21, Volume: 49, Issue:19
Synthesis of adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligands.
AID1560698Displacement of [3H]IP3 from rat IP3R1 expressed in human HEK cells assessed as dissociation constant by radioligand binding assay
AID1606919Agonist activity at rat IP3R1 expressed in HEK cells assessed as increase in calcium release in cytosol by measuring fluorescence signal by Mag-Fluo4 dye based assay relative to control2020Journal of medicinal chemistry, 05-28, Volume: 63, Issue:10
Both d- and l-Glucose Polyphosphates Mimic d-
AID1560700Agonist activity at IP3R1 in rat RBL-2H3 cells assessed as increase in ICRAC at 200 nM at -80 mV holding potential by whole cell patch clamp
AID270921Activity at rat IP3 type 1 receptor expressed in DT40 cell assessed by calcium ion mobilization relative to adenophostin A2006Journal of medicinal chemistry, Sep-21, Volume: 49, Issue:19
Synthesis of adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligands.
AID495143Displacement of [3H]IP3 from full-length rat recombinant IP3R1 expressed in chicken DT40 cells by equilibrium competitive binding assay2009Nature chemical biology, Sep, Volume: 5, Issue:9
Synthetic partial agonists reveal key steps in IP3 receptor activation.
AID661327Agonist activity at rat IP3R1 expressed in chicken DT40 cells assessed as induction of Ca2+ release2012Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
Contribution of phosphates and adenine to the potency of adenophostins at the IP₃ receptor: synthesis of all possible bisphosphates of adenophostin A.
AID92903Binding affinity towards rat liver membrane, measured using equilibrium competition binding with [3H]Inositol(1,4,5)P32001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.
AID1606915Agonist activity at rat IP3R1 expressed in HEK cells assessed as increase in calcium release in cytosol by measuring fluorescence signal by Mag-Fluo4 dye based assay2020Journal of medicinal chemistry, 05-28, Volume: 63, Issue:10
Both d- and l-Glucose Polyphosphates Mimic d-
AID195054Concentration causing maximal effect on [Ca2+] release from the intracellular stores of permealized hepatocytes2001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.
AID226480Hill coefficient, measured using equilibrium competition binding with [3H]Inositol(1,4,5)P32001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.
AID231371Ratio to Ins(1,4,5)P3 was measured(ratio greater than 1 denotes greater affinity and less than -1 denotes lesser affinity)2001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.
AID495142Agonist activity at rat recombinant IP3R1 expressed in chicken DT40 cells assessed as calcium release from intracellular stores2009Nature chemical biology, Sep, Volume: 5, Issue:9
Synthetic partial agonists reveal key steps in IP3 receptor activation.
AID661328Agonist activity at rat IP3R1 expressed in chicken DT40 cells assessed as Ca2+ release relative to control2012Journal of medicinal chemistry, Feb-23, Volume: 55, Issue:4
Contribution of phosphates and adenine to the potency of adenophostins at the IP₃ receptor: synthesis of all possible bisphosphates of adenophostin A.
AID495146Displacement of [3H]IP3 from rat recombinant IP3R1 binding core residue (224-604) expressed in chicken DT40 cells by equilibrium competitive binding assay2009Nature chemical biology, Sep, Volume: 5, Issue:9
Synthetic partial agonists reveal key steps in IP3 receptor activation.
AID1606920Displacement of [3H]-IP3 from IP3R1 in Wistar rat cerebellar membrane measured after 5 mins by liquid scintillation counting method2020Journal of medicinal chemistry, 05-28, Volume: 63, Issue:10
Both d- and l-Glucose Polyphosphates Mimic d-
AID495145Displacement of [3H]IP3 from rat recombinant N-terminal IP3R1 (1-604) expressed in chicken DT40 cells by equilibrium competitive binding assay2009Nature chemical biology, Sep, Volume: 5, Issue:9
Synthetic partial agonists reveal key steps in IP3 receptor activation.
AID1560697Agonist activity at rat IP3R1 expressed in human HEK cells assessed as increase in calcium release by Mag-fluo4 dye based assay relative to control
AID495144Ratio of EC50 to Kd for full-length rat recombinant DT40-IP3R1 expressed in chicken DT40 cells2009Nature chemical biology, Sep, Volume: 5, Issue:9
Synthetic partial agonists reveal key steps in IP3 receptor activation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (90)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's24 (26.67)18.2507
2000's49 (54.44)29.6817
2010's15 (16.67)24.3611
2020's2 (2.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.11 (24.57)
Research Supply Index4.53 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other90 (97.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]